Repligen (RGEN) Reports In-Line Q4 EPS, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
Tweet
Share
E-mailGet Alerts RGEN Hot Sheet
Price: $180.01 +0.63%
Revenue Growth %: +9.4%
Financial Fact:
Cost of product revenue: 11.24M
Today's EPS Names:
FNLC, LSBK, OVLY, More
Revenue Growth %: +9.4%
Financial Fact:
Cost of product revenue: 11.24M
Today's EPS Names:
FNLC, LSBK, OVLY, More
Join SI Premium – FREE
(Updated - February 21, 2024 7:40 AM EST)
Repligen (NASDAQ: RGEN) reported Q4 EPS of $0.33, in-line with the analyst estimate of $0.33. Revenue for the quarter came in at $155.7 million versus the consensus estimate of $155.38 million.
GUIDANCE:
Repligen sees 2024 EPS of $1.42-$1.49, versus the consensus of $1.77. Repligen sees 2024 revenue of $620-650 million, versus the consensus of $660.7 million.
For earnings history and earnings-related data on Repligen (RGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pharming Group N.V. (PHAR) Reports Q3 results; offers guidance
- Great Southern Bancorp (GSBC) Misses Q3 EPS by 12c
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
